Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Review

    The Significance of Bioactive Compounds in The Complex Realm of Cardiovascular Complications

    Sreejita Chakraborty1, Adib Hussain1, Arabinda Nayak1 Corresponding author

    1. 1Department of Pharmacology, Gupta College of Technological Sciences, Asansol, West Bengal, INDIA.

    CORRESPONDENCE

    Adib Hussain

    Department of Pharmacology, Gupta College of Technological Sciences, Asansol, West Bengal, INDIA.

    adibhussain1x@gmail.com

    Received: 27-01-2025; Revised: 06-03-2025; Accepted: 16-05-2025.

    Volume 19, Issue 37 · pp. 109–118 · PUBLISHED · DOI: 10.5530/phrev.20252203

    View on Pharmacogn. Rev. original site ↗

    ABSTRACT

    Leading cause of morbidity and death globally, Cardiovascular Diseases (CVDs) call for sensible preventive and treatment plans. Recent studies have concentrated on bioactive chemicals originating from natural dietary sources like fruits, vegetables, herbs, and marine resources for their cardioprotective action. Key bioactive substances like flavonoids, polyphenols, omega-3 fatty acids, and phytosterols show notable health advantages by enhancing endothelial function, lowering oxidative stress, controlling inflammation, and so changing lipid metabolism. Notwithstanding encouraging results about their capacity to reduce the risks of hypertension and atherosclerosis, practical application of them still faces difficulties including varied bioavailability, individual response variations, and the necessity of regular dosages. This review emphasizes the need for thorough clinical studies to prove their safety and efficacy as well as the possibilities of bioactive substances as supplementary treatments for improving cardiovascular health.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Chakraborty, S., Hussain, A., & Nayak, A. (). The Significance of Bioactive Compounds in The Complex Realm of Cardiovascular Complications. Pharmacognosy Reviews, 19(37), 109–118. https://doi.org/10.5530/phrev.20252203